Evidence map›Paper›PMID 28771521›Full record

ArticlePloS one2017

Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.

Alessandra De Riva, Maja Wållberg, Francesca Ronchi, Richard Coulson, Andrew Sage, Lucy Thorne, Ian Goodfellow, Kathy D McCoy, Miyuki Azuma, Anne Cooke and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Alessandra De RivaDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Maja WållbergDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Francesca RonchiMaurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland.
Richard CoulsonDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Andrew SageDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Lucy ThorneDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Ian GoodfellowDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Kathy D McCoyMaurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland.
Miyuki AzumaDepartment of Molecular Immunology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
Anne CookeDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Robert BuschDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-4132-0751
University of Cambridge · GBUniversity of Bern · CHTokyo Medical and Dental University · JP

Funding

British Heart Foundation FS/15/57/31557National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/M001083/1Versus Arthritis 18543Versus Arthritis 20648
6 · The paper itself

Abstract

Microbes, including viruses, influence type 1 diabetes (T1D) development, but many such influences remain undefined. Previous work on underlying immune mechanisms has focussed on cytokines and T cells. Here, we compared two nonobese diabetic (NOD) mouse colonies, NODlow and NODhigh, differing markedly in their cumulative T1D incidence (22% vs. 90% by 30 weeks in females). NODhigh mice harbored more complex intestinal microbiota, including several pathobionts; both colonies harbored segmented filamentous bacteria (SFB), thought to suppress T1D. Young NODhigh females had increased B-cell activation in their mesenteric lymph nodes. These phenotypes were transmissible. Co-housing of NODlow with NODhigh mice after weaning did not change T1D development, but T1D incidence was increased in female offspring of co-housed NODlow mice, which were exposed to the NODhigh environment both before and after weaning. These offspring also acquired microbiota and B-cell activation approaching those of NODhigh mice. In NODlow females, the low rate of T1D was unaffected by cyclophosphamide but increased by PD-L1 blockade. Thus, environmental exposures that are innocuous later in life may promote T1D progression if acquired early during immune development, possibly by altering B-cell activation and/or PD-L1 function. Moreover, T1D suppression in NOD mice by SFB may depend on the presence of other microbial influences. The complexity of microbial immune regulation revealed in this murine model may also be relevant to the environmental regulation of human T1D.

Indexed as

EnvironmentAnimalsB7-H1 AntigenB-LymphocytesCytokinesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1FemaleIncidenceLymphocyte ActivationMaleMiceMice, Inbred NODT-LymphocytesB7-H1 AntigenCytokines

Identifiers

PMID28771521
PMCPMC5542673
OpenAlexW2743377893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.